drugset / Trial / NCT03705351
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
Phase 1
Terminated
7 enrolled
Providence Health & Services
NovoCure Ltd. · collabUniversity of California, San Francisco · collab
NaSequentialOpen-labelTreatment
Summary
The study is an open-label pilot study in newly diagnosed glioblastoma patients following surgery. Eligible patients will receive treatment with tumor treating fields therapy using the Optune device starting less than 2 weeks prior to start of chemoradiation. Patients will receive radiation and temozolomide at a routine treatment dose and schedule.
Timeline
- Start
- 2019-12-02
- Primary completion
- 2021-02-24
- Completion
- 2022-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Temozolomide | Small molecule | — | — |